A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Suzetrigine | CAS 2649467-58-1 - Request Quote

Picture of Suzetrigine
SZ CAT No:SZ-S123001
CAS No
2649467-58-1
Mol.F.
C21H20F5N3O4
Mol.Wt.
473.4
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Suzetrigine is chemically 4-((2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxamido)picolinamide. Suzetrigine is supplied with detailed characterization data compliant with regulatory guideline. Suzetrigine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Suzetrigine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2649467-58-1

Purchase 2649467-58-1

Order 2649467-58-1

Enquire 2649467-58-1

price of 2649467-58-1

2649467-58-1 Supplier

2649467-58-1 Manufacturer

2649467-58-1 Exporter

buy high quality Suzetrigine

Purchase Suzetrigine

Suzetrigine suppliers

Suzetrigine manufacturers

Suzetrigine price

Order Suzetrigine

Enquire Suzetrigine

Suzetrigine cost

Suzetrigine Supplier

Suzetrigine Distributor

Suzetrigine for Method Validation

Suzetrigine Reference Standard

Suzetrigine for ANDA Filing

Suzetrigine for Forced Degradation Studies

Suzetrigine Identification Standards

Suzetrigine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,